Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules

Biochemical and Biophysical Research Communications

Volumn 386, Issue 2, 2009, Pages 338-344

  Mazzone, Graciela Luján ^a,b   Rigato, Igino ^a,c   Ostrow, J Donald ^d   Bossi, Fleur ^b   Bortoluzzi, Alessia ^a   Sukowati, Caecilia H C ^a,b   Tedesco, Francesco ^b   Tiribelli, Claudio ^a,b  

^a Centro Studi Fegato   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c San Vito al Tagliamento Hospital   (Italy)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Adhesion molecules; Atherosclerosis; Bilirubin; Endothelial cell activation; TNF

Indexed keywords

BILIRUBIN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL ADHESION; CELL LINE; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; NEUTROPHIL; PHYSIOLOGY; UMBILICAL CORD;

BILIRUBIN; CELL ADHESION; CELL LINE; E-SELECTIN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NEUTROPHILS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL CORD; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 67649660192     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.029     Document Type: Article

References (20)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Kelly M., Hwang J.M., and Kubes P. Modulating leukocyte recruitment in inflammation. J. Allergy Clin. Immunol. 120 (2007) 3-10
3. Young J.L., Libby P., and Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb. Haemost. 88 (2002) 554-567
4. Neuzil J., and Stocker R. Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett. 331 (1993) 281-284
5. Rigato I., Ostrow J.D., and Tiribelli C. Bilirubin and the risk of common non-hepatic diseases. Trends Mol. Med. 11 (2005) 277-283
6. Stocker R., and Keaney Jr. J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84 (2004) 1381-1478
7. Keshavan P., Deem T.L., Schwemberger S.J., Babcock G.F., Cook-Mills J.M., and Zucker S.D. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J. Immunol. 174 (2005) 3709-3718
8. Tedesco F., Pausa M., Nardon E., Introna M., Mantovani A., and Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. 185 (1997) 1619-1627
9. Garlanda C., Parravicini C., Sironi M., De Rossi M., Wainstok D.C., Carozzi F., Bussolino F., Colotta F., Mantovani A., and Vecchi A. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors. Proc. Natl. Acad. Sci. USA 91 (1994) 7291-7295
10. McDonagh A.F., and Assisi F. The ready isomerization of bilirubin IX- in aqueous solution. Biochem. J. 129 (1972) 797-800
11. Roca L., Calligaris S., Wennberg R.P., Ahlfors C.E., Malik S.G., Ostrow J.D., and Tiribelli C. Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method. Pediatr. Res. 60 (2006) 724-728
12. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
13. Rossi F., Della B., Grzeskowiak V.M., and Bazzoni F. Studies on molecular regulation of phagocytosis in neutrophils. Con A-mediated ingestion and associated respiratory burst independent of phosphoinositide turnover, rise in [Ca2+]i, and arachidonic acid release. J. Immunol. 142 (1989) 1652-1660
14. Polenghi A., Bossi F., Fischetti F., Durigutto P., Cabrelle A., Tamassia N., Cassatella M.A., Montecucco C., Tedesco F., and de Bernard M. The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo. J. Immunol. 178 (2007) 1312-1320
15. Djousse L., Levy D., Cupples L.A., Evans J.C., D'Agostino R.B., and Ellison R.C. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am. J. Cardiol. 87 (2001) 1196-1200
16. Vitek L., Jirsa M., Brodanova M., Kalab M., Marecek Z., Danzig V., Novotny L., and Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160 (2002) 449-456
17. Ollinger R., Bilban M., Erat A., Froio A., McDaid J., Tyagi S., Csizmadia E., Graca-Souza A.V., Liloia A., Soares M.P., Otterbein L.E., Usheva A., Yamashita K., and Bach F.H. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112 (2005) 1030-1039
18. Blankenberg S., Barbaux S., and Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 170 (2003) 191-203
19. Jacobsen J., and Wennberg R.P. Determination of unbound bilirubin in the serum of newborns. Clin. Chem. 20 (1974) 783
20. Nelson T., Jacobsen J., and Wennberg R.P. Effect of pH on the interaction of bilirubin with albumin and tissue culture cells. Pediatr. Res. 8 (1974) 963-967